Medical Journals

Toll-like Receptor 2 Modulates Left Ventricular Function Following Ischemia-reperfusion Injury.

Authors:
  • Sakata Yasushi
  • Dong Jian-Wen
  • Vallejo Jesus G
  • Huang Chien-Hua
  • Baker J Scott
  • Tracey Kevin J
  • Tacheuchi Osamu
  • Akira Shizuo
  • Mann Douglas L

From: Winters Center for Heart Failure Research, 1709 Dryden-BCM, 620-Rm 9.83, Houston, TX 77030, USA.

American journal of physiology. Heart and circulatory physiology

  • Publish Date: Jan 2007
  • ISSN: 0363-6135
  • Volume: 292
  • Issue: 1
  • Pages: H503-9
  • Medium: Print
  • Language: English
  • Citation (JAMA): Sakata Yasushi, Dong Jian-Wen, Vallejo Jesus G, et al. Toll-like Receptor 2 Modulates Left Ventricular Function Following Ischemia-reperfusion Injury.. Am. J. Physiol. Heart Circ. Physiol. Jan 2007;292:H503-9

Abstract

Production of proinflammatory cytokines contributes to cardiac dysfunction during ischemia-reperfusion. The principal mechanism responsible for the induction of this innate stress response during periods of myocardial ischemia-reperfusion remains unknown. Toll-like receptor 2 (TLR2) is a highly conserved pattern recognition receptor that has been implicated in the innate immune response to a variety of pathogens. However, TLR2 may also mediate inflammation in response to noninfectious injury. We therefore hypothesized that TLR2 is essential for modulating myocardial inflammation and left ventricular (LV) function during ischemia-reperfusion injury. Susceptibility to myocardial ischemia-reperfusion injury following ischemia-reperfusion was determined in Langendorff-perfused hearts isolated from wild-type mice and mice deficient in TLR2 (TLR2D) and Toll interleukin receptor domain-containing adaptor protein. After ischemia-reperfusion, contractile performance was significantly impaired in hearts from wild-type mice as demonstrated by a lower recovery of LV developed pressure relative to TLR2D hearts. Creatinine kinase levels were similar in both groups after reperfusion. Contractile dysfunction in wild-type hearts was associated with elevated cardiac levels of TNF and IL-1beta. Ischemia-reperfusion-induced LV dysfunction was reversed by treatment with the recombinant TNF blocking protein etanercept. These studies show for the first time that TLR2 signaling importantly contributes to the LV dysfunction that occurs following ischemia-reperfusion. Thus disruption of TLR2-mediated signaling may be helpful to induce immediate or delayed myocardial protection from ischemia-reperfusion injury.

Mesh Headings (Keywords): Animals, Mice, Mice, Inbred C57BL, Mice, Knockout, Myocardial Reperfusion Injury, Toll-Like Receptor 2, Ventricular Dysfunction, Left


Check for Full Text / PubMed Unique Identifier (PMID): 16980352


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.